Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?

LM de la Maza, TL Darville, S Pal - Expert review of vaccines, 2021 - Taylor & Francis
Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. Antibiotic treatment does not prevent against reinfection and a …
被引用次数：30 相关文章

Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?

LM de la Maza, TL Darville, S Pal - Expert Review of Vaccines, 2021 - europepmc.org
Attempts to protect against trachoma, an ocular disease caused by Chlamydia trachomatis,
started a 100 years ago. The realization in the 1960's that C. trachomatis was also a …
[HTML] nih.gov

[HTML][HTML] Chlamydia vaccines: where are we and how far is there to go?

LM de la Maza, T Darville, S Pal - Expert review of vaccines, 2021 - ncbi.nlm.nih.gov
Attempts to protect against trachoma, an ocular disease caused by Chlamydia trachomatis,
started a 100 years ago. The realization in the 1960's that C. trachomatis was also a …

Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?

LM de la Maza, TL Darville… - Expert review of …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. Antibiotic treatment does not prevent against reinfection and a …
[PDF] escholarship.org

[PDF][PDF] Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?

LM de la Maza, TL Darville, S Pal - Expert review of vaccines, 2021 - escholarship.org
IntroductionChlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. Antibiotic treatment does not prevent against reinfection and a …